{"entity":{"type":"insider","cik":"0001597152","url":"/insider/0001597152","json_url":"/insider/0001597152.json","name":"Menzaghi Frederique Ph.D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":48,"n_filings":45,"first":"2015-07-06","last":"2023-06-27","span_basis":"filed_date"},"name_variants":[{"name":"Menzaghi Frederique Ph.D.","source":"filing","n_filings":45,"first_seen":"2015-07-06","last_seen":"2023-06-27"}],"transactions":[{"id":8500724,"accession":"0001209191-23-039883","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-039883","line_url":"/filing/0001209191-23-039883#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2993.0,"shares_display":"2,993","price_per_share":3.51,"price_display":"3.51","price_state":"stated","total_value":10505.43,"total_display":"10,505.43","total_whole":"10,505","shares_owned_after":153747.0,"shares_owned_after_display":"153,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-23","filed_date":"2023-06-27","scope":"insider"},{"id":8072167,"accession":"0001209191-23-023605","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023605","line_url":"/filing/0001209191-23-023605#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2733.0,"shares_display":"2,733","price_per_share":4.91,"price_display":"4.91","price_state":"stated","total_value":13419.03,"total_display":"13,419.03","total_whole":"13,419","shares_owned_after":156740.0,"shares_owned_after_display":"156,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-04","filed_date":"2023-04-06","scope":"insider"},{"id":8215096,"accession":"0001209191-23-016795","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016795","line_url":"/filing/0001209191-23-016795#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6802.0,"shares_display":"6,802","price_per_share":9.71,"price_display":"9.71","price_state":"stated","total_value":66047.42,"total_display":"66,047.42","total_whole":"66,047","shares_owned_after":159473.0,"shares_owned_after_display":"159,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-07","scope":"insider"},{"id":6107902,"accession":"0001209191-22-062632","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062632","line_url":"/filing/0001209191-22-062632#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3506.0,"shares_display":"3,506","price_per_share":11.27,"price_display":"11.27","price_state":"stated","total_value":39512.62,"total_display":"39,512.62","total_whole":"39,513","shares_owned_after":166275.0,"shares_owned_after_display":"166,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-23","scope":"insider"},{"id":6121698,"accession":"0001209191-22-023241","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-023241","line_url":"/filing/0001209191-22-023241#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1784.0,"shares_display":"1,784","price_per_share":11.91,"price_display":"11.91","price_state":"stated","total_value":21247.44,"total_display":"21,247.44","total_whole":"21,247","shares_owned_after":169781.0,"shares_owned_after_display":"169,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-01","filed_date":"2022-04-05","scope":"insider"},{"id":6243375,"accession":"0001209191-22-013986","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-013986","line_url":"/filing/0001209191-22-013986#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2114.0,"shares_display":"2,114","price_per_share":10.29,"price_display":"10.29","price_state":"stated","total_value":21753.06,"total_display":"21,753.06","total_whole":"21,753","shares_owned_after":171565.0,"shares_owned_after_display":"171,565","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-25","filed_date":"2022-03-01","scope":"insider"},{"id":5001392,"accession":"0001209191-21-054302","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-054302","line_url":"/filing/0001209191-21-054302#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3847.0,"shares_display":"3,847","price_per_share":14.2,"price_display":"14.20","price_state":"stated","total_value":54627.4,"total_display":"54,627.40","total_whole":"54,627","shares_owned_after":141072.0,"shares_owned_after_display":"141,072","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-30","filed_date":"2021-09-01","scope":"insider"},{"id":4884240,"accession":"0001209191-21-018656","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-018656","line_url":"/filing/0001209191-21-018656#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3358.0,"shares_display":"3,358","price_per_share":17.98,"price_display":"17.98","price_state":"stated","total_value":60376.84,"total_display":"60,376.84","total_whole":"60,377","shares_owned_after":119319.0,"shares_owned_after_display":"119,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-08","scope":"insider"},{"id":5286390,"accession":"0001209191-21-014549","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-014549","line_url":"/filing/0001209191-21-014549#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5003.0,"shares_display":"5,003","price_per_share":19.33,"price_display":"19.33","price_state":"stated","total_value":96707.99,"total_display":"96,707.99","total_whole":"96,708","shares_owned_after":112677.0,"shares_owned_after_display":"112,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-25","filed_date":"2021-02-25","scope":"insider"},{"id":3096496,"accession":"0001209191-20-065581","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-065581","line_url":"/filing/0001209191-20-065581#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2812.0,"shares_display":"2,812","price_per_share":15.3,"price_display":"15.30","price_state":"stated","total_value":43023.6,"total_display":"43,023.60","total_whole":"43,024","shares_owned_after":109680.0,"shares_owned_after_display":"109,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-30","filed_date":"2020-12-30","scope":"insider"},{"id":2965000,"accession":"0001209191-20-025307","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-025307","line_url":"/filing/0001209191-20-025307#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12894.0,"shares_display":"12,894","price_per_share":15.58,"price_display":"15.58","price_state":"stated","total_value":200888.52,"total_display":"200,888.52","total_whole":"200,889","shares_owned_after":104492.0,"shares_owned_after_display":"104,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-21","filed_date":"2020-04-21","scope":"insider"},{"id":8320898,"accession":"0001209191-19-054364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-054364","line_url":"/filing/0001209191-19-054364#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":19.91,"price_display":"19.91","price_state":"stated","total_value":79640.0,"total_display":"79,640.00","total_whole":"79,640","shares_owned_after":63886.0,"shares_owned_after_display":"63,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-25","filed_date":"2019-10-29","scope":"insider"},{"id":7872929,"accession":"0001209191-19-053798","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-053798","line_url":"/filing/0001209191-19-053798#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":19.33,"price_display":"19.33","price_state":"stated","total_value":77320.0,"total_display":"77,320.00","total_whole":"77,320","shares_owned_after":67886.0,"shares_owned_after_display":"67,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-18","filed_date":"2019-10-22","scope":"insider"},{"id":8601278,"accession":"0001209191-19-053312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-053312","line_url":"/filing/0001209191-19-053312#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":18.7,"price_display":"18.70","price_state":"stated","total_value":74800.0,"total_display":"74,800.00","total_whole":"74,800","shares_owned_after":71886.0,"shares_owned_after_display":"71,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-11","filed_date":"2019-10-16","scope":"insider"},{"id":8010536,"accession":"0001209191-19-052768","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-052768","line_url":"/filing/0001209191-19-052768#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":19.19,"price_display":"19.19","price_state":"stated","total_value":76760.0,"total_display":"76,760.00","total_whole":"76,760","shares_owned_after":75886.0,"shares_owned_after_display":"75,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-04","filed_date":"2019-10-08","scope":"insider"},{"id":8493243,"accession":"0001209191-19-048602","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-048602","line_url":"/filing/0001209191-19-048602#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":22.92,"price_display":"22.92","price_state":"stated","total_value":458400.0,"total_display":"458,400.00","total_whole":"458,400","shares_owned_after":79886.0,"shares_owned_after_display":"79,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":7884077,"accession":"0001209191-19-044643","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-044643","line_url":"/filing/0001209191-19-044643#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":23.24,"price_display":"23.24","price_state":"stated","total_value":464800.0,"total_display":"464,800.00","total_whole":"464,800","shares_owned_after":99886.0,"shares_owned_after_display":"99,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-01","filed_date":"2019-08-05","scope":"insider"},{"id":7871916,"accession":"0001209191-19-042806","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-042806","line_url":"/filing/0001209191-19-042806#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8996.0,"shares_display":"8,996","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":247390.0,"total_display":"247,390.00","total_whole":"247,390","shares_owned_after":119886.0,"shares_owned_after_display":"119,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-17","filed_date":"2019-07-19","scope":"insider"},{"id":8492270,"accession":"0001209191-19-041022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-041022","line_url":"/filing/0001209191-19-041022#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":21.9,"price_display":"21.90","price_state":"stated","total_value":438000.0,"total_display":"438,000.00","total_whole":"438,000","shares_owned_after":128882.0,"shares_owned_after_display":"128,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-03","scope":"insider"},{"id":8119513,"accession":"0001209191-19-033516","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-033516","line_url":"/filing/0001209191-19-033516#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11397.0,"shares_display":"11,397","price_per_share":21.19,"price_display":"21.19","price_state":"stated","total_value":241502.43,"total_display":"241,502.43","total_whole":"241,502","shares_owned_after":148882.0,"shares_owned_after_display":"148,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-29","filed_date":"2019-05-30","scope":"insider"},{"id":8152955,"accession":"0001209191-19-019509","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-019509","line_url":"/filing/0001209191-19-019509#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16803.0,"shares_display":"16,803","price_per_share":18.87,"price_display":"18.87","price_state":"stated","total_value":317072.61,"total_display":"317,072.61","total_whole":"317,073","shares_owned_after":122779.0,"shares_owned_after_display":"122,779","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-13","filed_date":"2019-03-14","scope":"insider"},{"id":8152952,"accession":"0001209191-19-019509","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-019509","line_url":"/filing/0001209191-19-019509#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Chief Scientific Off,SVP-R&D)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Off,SVP-R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Off,SVP-R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3197.0,"shares_display":"3,197","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":55947.5,"total_display":"55,947.50","total_whole":"55,948","shares_owned_after":139582.0,"shares_owned_after_display":"139,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-12","filed_date":"2019-03-14","scope":"insider"},{"id":7836950,"accession":"0001209191-19-015839","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-015839","line_url":"/filing/0001209191-19-015839#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Sr VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (Sr VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":26250.0,"total_display":"26,250.00","total_whole":"26,250","shares_owned_after":142779.0,"shares_owned_after_display":"142,779","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-28","filed_date":"2019-03-04","scope":"insider"},{"id":8412338,"accession":"0001209191-19-014161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-014161","line_url":"/filing/0001209191-19-014161#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Sr VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (Sr VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":38500.0,"total_display":"38,500.00","total_whole":"38,500","shares_owned_after":144279.0,"shares_owned_after_display":"144,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-25","filed_date":"2019-02-27","scope":"insider"},{"id":8003057,"accession":"0001209191-19-000406","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-000406","line_url":"/filing/0001209191-19-000406#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Sr VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (Sr VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4300.0,"shares_display":"4,300","price_per_share":12.53,"price_display":"12.53","price_state":"stated","total_value":53879.0,"total_display":"53,879.00","total_whole":"53,879","shares_owned_after":146479.0,"shares_owned_after_display":"146,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-28","filed_date":"2019-01-02","scope":"insider"},{"id":6479917,"accession":"0001209191-18-061253","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-061253","line_url":"/filing/0001209191-18-061253#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Sr VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (Sr VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":18.36,"price_display":"18.36","price_state":"stated","total_value":55080.0,"total_display":"55,080.00","total_whole":"55,080","shares_owned_after":139000.0,"shares_owned_after_display":"139,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider"},{"id":6560385,"accession":"0001209191-18-057307","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-057307","line_url":"/filing/0001209191-18-057307#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Sr VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (Sr VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":18.77,"price_display":"18.77","price_state":"stated","total_value":56310.0,"total_display":"56,310.00","total_whole":"56,310","shares_owned_after":142000.0,"shares_owned_after_display":"142,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-01","filed_date":"2018-11-05","scope":"insider"},{"id":6267661,"accession":"0001209191-18-053764","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-053764","line_url":"/filing/0001209191-18-053764#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Sr VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (Sr VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":23.99,"price_display":"23.99","price_state":"stated","total_value":71970.0,"total_display":"71,970.00","total_whole":"71,970","shares_owned_after":95000.0,"shares_owned_after_display":"95,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-01","filed_date":"2018-10-03","scope":"insider"},{"id":6369751,"accession":"0001209191-18-049921","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-049921","line_url":"/filing/0001209191-18-049921#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Sr VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (Sr VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":19.81,"price_display":"19.81","price_state":"stated","total_value":59430.0,"total_display":"59,430.00","total_whole":"59,430","shares_owned_after":98000.0,"shares_owned_after_display":"98,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-06","scope":"insider"},{"id":6559515,"accession":"0001209191-18-048017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-048017","line_url":"/filing/0001209191-18-048017#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Sr VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (Sr VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":18.89,"price_display":"18.89","price_state":"stated","total_value":56670.0,"total_display":"56,670.00","total_whole":"56,670","shares_owned_after":101000.0,"shares_owned_after_display":"101,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-20","filed_date":"2018-08-22","scope":"insider"},{"id":6101557,"accession":"0001209191-18-041722","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-041722","line_url":"/filing/0001209191-18-041722#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Sr VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (Sr VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":57000.0,"total_display":"57,000.00","total_whole":"57,000","shares_owned_after":104000.0,"shares_owned_after_display":"104,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-05","scope":"insider"},{"id":6044027,"accession":"0001209191-18-035933","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-035933","line_url":"/filing/0001209191-18-035933#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Sr VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (Sr VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":15.49,"price_display":"15.49","price_state":"stated","total_value":46470.0,"total_display":"46,470.00","total_whole":"46,470","shares_owned_after":107000.0,"shares_owned_after_display":"107,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-01","filed_date":"2018-06-05","scope":"insider"},{"id":6425151,"accession":"0001209191-18-033520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-033520","line_url":"/filing/0001209191-18-033520#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Sr VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (Sr VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":15.19,"price_display":"15.19","price_state":"stated","total_value":136710.0,"total_display":"136,710.00","total_whole":"136,710","shares_owned_after":110000.0,"shares_owned_after_display":"110,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-23","filed_date":"2018-05-25","scope":"insider"},{"id":6493867,"accession":"0001209191-18-011372","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-011372","line_url":"/filing/0001209191-18-011372#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Sr VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (Sr VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":15.02,"price_display":"15.02","price_state":"stated","total_value":45060.0,"total_display":"45,060.00","total_whole":"45,060","shares_owned_after":119000.0,"shares_owned_after_display":"119,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-15","filed_date":"2018-02-20","scope":"insider"},{"id":6419022,"accession":"0001209191-18-005679","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-005679","line_url":"/filing/0001209191-18-005679#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (Sr VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (Sr VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":225000.0,"total_display":"225,000.00","total_whole":"225,000","shares_owned_after":122000.0,"shares_owned_after_display":"122,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-24","filed_date":"2018-01-26","scope":"insider"},{"id":4267743,"accession":"0001209191-17-048459","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-048459","line_url":"/filing/0001209191-17-048459#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":45000.0,"total_display":"45,000.00","total_whole":"45,000","shares_owned_after":117000.0,"shares_owned_after_display":"117,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-04","filed_date":"2017-08-10","scope":"insider"},{"id":4832322,"accession":"0001209191-17-045566","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-045566","line_url":"/filing/0001209191-17-045566#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":45000.0,"total_display":"45,000.00","total_whole":"45,000","shares_owned_after":120000.0,"shares_owned_after_display":"120,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-14","filed_date":"2017-07-18","scope":"insider"},{"id":3042836,"accession":"0001209191-16-115077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-115077","line_url":"/filing/0001209191-16-115077#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":54000.0,"total_display":"54,000.00","total_whole":"54,000","shares_owned_after":123000.0,"shares_owned_after_display":"123,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-20","filed_date":"2016-04-20","scope":"insider"},{"id":2874261,"accession":"0001209191-16-095332","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-095332","line_url":"/filing/0001209191-16-095332#line-2","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":9000.0,"total_display":"9,000.00","total_whole":"9,000","shares_owned_after":129000.0,"shares_owned_after_display":"129,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-03","filed_date":"2016-02-03","scope":"insider"},{"id":2874250,"accession":"0001209191-16-095332","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-095332","line_url":"/filing/0001209191-16-095332#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":9.05,"price_display":"9.05","price_state":"stated","total_value":45250.0,"total_display":"45,250.00","total_whole":"45,250","shares_owned_after":130000.0,"shares_owned_after_display":"130,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-01","filed_date":"2016-02-03","scope":"insider"},{"id":2816668,"accession":"0001209191-16-088839","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-088839","line_url":"/filing/0001209191-16-088839#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":16.8,"price_display":"16.80","price_state":"stated","total_value":100800.0,"total_display":"100,800.00","total_whole":"100,800","shares_owned_after":135000.0,"shares_owned_after_display":"135,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-05","scope":"insider"},{"id":8775182,"accession":"0001209191-15-083296","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-083296","line_url":"/filing/0001209191-15-083296#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":16.21,"price_display":"16.21","price_state":"stated","total_value":97260.0,"total_display":"97,260.00","total_whole":"97,260","shares_owned_after":141000.0,"shares_owned_after_display":"141,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-01","filed_date":"2015-12-03","scope":"insider"},{"id":8829621,"accession":"0001209191-15-078183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-078183","line_url":"/filing/0001209191-15-078183#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":14.26,"price_display":"14.26","price_state":"stated","total_value":85560.0,"total_display":"85,560.00","total_whole":"85,560","shares_owned_after":147000.0,"shares_owned_after_display":"147,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-02","filed_date":"2015-11-03","scope":"insider"},{"id":8793972,"accession":"0001209191-15-073957","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-073957","line_url":"/filing/0001209191-15-073957","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":13.9525,"price_display":"13.95","price_state":"stated","total_value":83715.0,"total_display":"83,715.00","total_whole":"83,715","shares_owned_after":154500.0,"shares_owned_after_display":"154,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-01","filed_date":"2015-10-05","scope":"insider","n_lines":2},{"id":8786177,"accession":"0001209191-15-069518","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-069518","line_url":"/filing/0001209191-15-069518#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":18.63,"price_display":"18.63","price_state":"stated","total_value":130410.0,"total_display":"130,410.00","total_whole":"130,410","shares_owned_after":159000.0,"shares_owned_after_display":"159,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-01","filed_date":"2015-09-03","scope":"insider"},{"id":8786054,"accession":"0001209191-15-064107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-064107","line_url":"/filing/0001209191-15-064107#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":21.41,"price_display":"21.41","price_state":"stated","total_value":149870.0,"total_display":"149,870.00","total_whole":"149,870","shares_owned_after":166000.0,"shares_owned_after_display":"166,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-08-05","scope":"insider"},{"id":8812464,"accession":"0001209191-15-059619","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-059619","line_url":"/filing/0001209191-15-059619#line-1","is_derivative":false,"issuer_cik":"0001346830","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001346830","owner_cik":"0001597152","owner_name":"Menzaghi Frederique Ph.D.","owner_display_name":"Menzaghi Frederique Ph.D.","owner_url":"/insider/0001597152","role":"Officer (VP-Research & Development)","role_mark":"O","role_mark_label":"Officer (VP-Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP-Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":12.22,"price_display":"12.22","price_state":"stated","total_value":85540.0,"total_display":"85,540.00","total_whole":"85,540","shares_owned_after":173000.0,"shares_owned_after_display":"173,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":48,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":48,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":48},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001346830","name":"Cara Therapeutics, Inc.","url":"/issuer/0001346830","role":"Officer (Chief Scientific Off,SVP-R&D)","n_filings":45,"first_seen":"2015-07-06","last_seen":"2023-06-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001597152","retrieved_at":"2026-08-25T21:25:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}